Atlas Trials

The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals

Clinical trial NCT05552950 · UNKNOWN

Trial details

NCT number
NCT05552950
Sponsor
Chemi-Pharm AS
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
SARS CoV 2 Infection
Start date
2022-05-01
Primary completion
2023-07-31
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.